123 related articles for article (PubMed ID: 7698175)
1. The novel antiepileptic drug, lamotrigine, exerts prodystonic effects in a mutant hamster model of generalized dystonia.
Richter A; Löschmann PA; Löscher W
Eur J Pharmacol; 1994 Nov; 264(3):345-51. PubMed ID: 7698175
[TBL] [Abstract][Full Text] [Related]
2. Prodystonic effects of riluzole in an animal model of idiopathic dystonia related to decreased total power in the red nucleus?
Richter A; Gernert M; Löscher W
Eur J Pharmacol; 1997 Aug; 332(2):133-41. PubMed ID: 9286614
[TBL] [Abstract][Full Text] [Related]
3. Effects of pharmacological manipulation of GABAergic neurotransmission in a new mutant hamster model of paroxysmal dystonia.
Fredow G; Löscher W
Eur J Pharmacol; 1991 Jan; 192(2):207-19. PubMed ID: 1851702
[TBL] [Abstract][Full Text] [Related]
4. Increased levels of kynurenic acid in brains of genetically dystonic hamsters.
Richter A; Loscher W; Baran H; Gramer M
Brain Res Dev Brain Res; 1996 Mar; 92(1):111-6. PubMed ID: 8861729
[TBL] [Abstract][Full Text] [Related]
5. Alterations in pharmacological sensitivity of GABAergic but not dopaminergic and glutamatergic systems during ontogenesis in dystonic mutant hamsters.
Richter A; Löscher W
Eur J Pharmacol; 1993 Jan; 231(1):111-9. PubMed ID: 8383061
[TBL] [Abstract][Full Text] [Related]
6. The kappa-opioid receptor agonist, U50,488H, exerts antidystonic activity in a mutant hamster model of generalized dystonia.
Richter A; Löscher W
Eur J Pharmacol; 1993 May; 236(2):289-94. PubMed ID: 8391460
[TBL] [Abstract][Full Text] [Related]
7. Effects of pharmacological manipulation of dopaminergic and cholinergic neurotransmission in genetically dystonic hamsters.
Löscher W; Fredow G
Eur J Pharmacol; 1992 Mar; 213(1):31-9. PubMed ID: 1323471
[TBL] [Abstract][Full Text] [Related]
8. The sz mutant hamster: a genetic model of epilepsy or of paroxysmal dystonia?
Löscher W; Fisher JE; Schmidt D; Fredow G; Hönack D; Iturrian WB
Mov Disord; 1989; 4(3):219-32. PubMed ID: 2779593
[TBL] [Abstract][Full Text] [Related]
9. Paradoxical aggravation of paroxysmal dystonia during chronic treatment with phenobarbital in a genetic rodent model.
Richter A; Löscher W
Eur J Pharmacol; 2000 Jun; 397(2-3):343-50. PubMed ID: 10844133
[TBL] [Abstract][Full Text] [Related]
10. Effects of pharmacological entopeduncular manipulations on idiopathic dystonia in the dt(sz) mutant hamster.
Hamann M; Sander SE; Kreil A; Richter A
J Neural Transm (Vienna); 2010 Jun; 117(6):747-57. PubMed ID: 20454986
[TBL] [Abstract][Full Text] [Related]
11. Role of striatal NMDA receptor subunits in a model of paroxysmal dystonia.
Avchalumov Y; Sander SE; Richter F; Porath K; Hamann M; Bode C; Kirschstein T; Köhling R; Richter A
Exp Neurol; 2014 Nov; 261():677-84. PubMed ID: 25139804
[TBL] [Abstract][Full Text] [Related]
12. Antidystonic effects of the NMDA receptor antagonists memantine, MK-801 and CGP 37849 in a mutant hamster model of paroxysmal dystonia.
Richter A; Fredow G; Löscher W
Neurosci Lett; 1991 Nov; 133(1):57-60. PubMed ID: 1686481
[TBL] [Abstract][Full Text] [Related]
13. Gabapentin decreases the severity of dystonia at low doses in a genetic animal model of paroxysmal dystonic choreoathetosis.
Richter A; Löscher W
Eur J Pharmacol; 1999 Mar; 369(3):335-8. PubMed ID: 10225372
[TBL] [Abstract][Full Text] [Related]
14. The atypical neuroleptic, clozapine, exerts antidystonic activity in a mutant hamster model. Comparison with haloperidol.
Richter A; Löscher W
Eur J Pharmacol; 1993 Oct; 242(3):309-12. PubMed ID: 8281996
[TBL] [Abstract][Full Text] [Related]
15. Alterations in spontaneous single unit activity of striatal subdivisions during ontogenesis in mutant dystonic hamsters.
Gernert M; Richter A; Löscher W
Brain Res; 1999 Mar; 821(2):277-85. PubMed ID: 10064814
[TBL] [Abstract][Full Text] [Related]
16. Effects of locally administered pentylenetetrazole on nigral single unit activity and severity of dystonia in a genetic model of paroxysmal dystonia.
Fedrowitz M; Hamann M; Rehders JH; Richter A; Gernert M
J Neurosci Res; 2002 Jun; 68(5):595-603. PubMed ID: 12111849
[TBL] [Abstract][Full Text] [Related]
17. (+)-WIN 55,212-2, a novel cannabinoid receptor agonist, exerts antidystonic effects in mutant dystonic hamsters.
Richter A; Löscher W
Eur J Pharmacol; 1994 Nov; 264(3):371-7. PubMed ID: 7698178
[TBL] [Abstract][Full Text] [Related]
18. Gonadal sex hormones and dystonia: experimental studies in genetically dystonic hamsters.
Löscher W; Blanke T; Richter A; Hoppen HO
Mov Disord; 1995 Jan; 10(1):92-102. PubMed ID: 7885361
[TBL] [Abstract][Full Text] [Related]
19. Antidystonic efficacy of nitric oxide synthase inhibitors in a rodent model of primary paroxysmal dystonia.
Richter A; Löschmann PA; Löscher W
Br J Pharmacol; 2000 Nov; 131(5):921-6. PubMed ID: 11053212
[TBL] [Abstract][Full Text] [Related]
20. Persistent changes of corticostriatal plasticity in dt(sz) mutant hamsters after age-dependent remission of dystonia.
Avchalumov Y; Volkmann CE; Rückborn K; Hamann M; Kirschstein T; Richter A; Köhling R
Neuroscience; 2013 Oct; 250():60-9. PubMed ID: 23827309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
